Reference values for thrombin dynamics in platelet rich plasma

References

• Van Veen JJ, Gatt A, Makris M. Thrombin generation testing in routine clinical practice: are we there yet? Br J Haematol 2008;142(6):889–903. doi:10.1111/j.1365-2141.2008.07267.x. PMID:18564356.
   PubMed Web of Science ®Google Scholar
• Adams M. Assessment of thrombin generation: useful or hype? Semin Thromb Hemost 2009;35(1):104–110. doi:10.1055/s-0029-1214153. PMID:19308898.
   PubMed Web of Science ®Google Scholar
• Smid M, Dielis AW, Winkens M, Spronk HM, van Oerle R, Hamulyak K, Prins MH, Rosing J, Waltenberger JL, Ten Cate H. Thrombin generation in patients with a first acute myocardial infarction. J Thromb Haemost 2011;9(3):450–456. doi:10.1111/j.1538-7836.2010.04162.x. PMID: 21143375.
   PubMed Web of Science ®Google Scholar
• Castoldi E, Rosing J. Thrombin generation tests. Thromb Res 2011;127(Suppl 3):S21–S25. doi:10.1016/s0049-3848(11)70007-x. PMID:21262433.
   PubMedGoogle Scholar
• Dargaud Y, Prevost C, Lienhart A, Claude Bordet J, Negrier C. Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots. Haemophilia 2011;17(6):957–961. doi:10.1111/j.1365-2516.2011.02526.x. PMID: 21453422.
   PubMed Web of Science ®Google Scholar
• Ninivaggi M, Apitz-Castro R, Dargaud Y, de Laat B, Hemker HC, Lindhout T. Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay. Clin Chem 2012;58(8):1252–1259. doi:10.1373/clinchem.2012.184077. PMID:22665918.
   PubMed Web of Science ®Google Scholar
• Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002;32(5–6):249–253. doi:10.1159/000073575. PMID:13679651.
   PubMedGoogle Scholar
• Ninivaggi M, Kelchtermans H, Lindhout T, de Laat B. Conformation of beta2glycoprotein I and its effect on coagulation. Thromb Res 2012;130(Suppl 1):S33–S36. doi:10.1016/j.thromres.2012.08.269. PMID:22925530.
   PubMedGoogle Scholar
• Tripodi A. The long-awaited whole-blood thrombin generation test. Clin Chem 2012;58(8):1173–1175. doi:10.1373/clinchem.2012.189266. PMID: 22685127.
   PubMed Web of Science ®Google Scholar
• Coen Hemker H, Hemker PW, Al Dieri R. The technique of measuring thrombin generation with fluorescent substrates: 4. The H-transform, a mathematical procedure to obtain thrombin concentrations without external calibration. Thromb Haemost 2009;101(1):171–177. doi:10.1160/th08-09-0562. PMID:19132205.
   PubMed Web of Science ®Google Scholar
• Kremers RM, Peters TC, Wagenvoord RJ, Hemker HC. The balance of pro- and anticoagulant processes underlying thrombin generation. J Thromb Haemost 2015;13(3):437–447. doi:10.1111/jth.12798. PMID:25421744.
   PubMed Web of Science ®Google Scholar
• Bungay SD, Gentry PA, Gentry RD. A mathematical model of lipid-mediated thrombin generation. Math Med Biol 2003;20(1):105–129. doi:10.1093/imammb/20.1.105. PMID:12974500.
   PubMed Web of Science ®Google Scholar
• Hemker HC, Willems GM, Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986;56(1):9–17. doi:10.1055/s-0038-1661594. PMID:2430342.
   PubMed Web of Science ®Google Scholar
• Beguin S, Kessels H, Dol F, Hemker HC. The consumption of antithrombin III during coagulation, its consequences for the calculation of prothrombinase activity and the standardisation of heparin activity. Thromb Haemost 1992;68(2):136–142. doi:10.1055/s-0038-1656338. PMID:1412157.
   PubMed Web of Science ®Google Scholar
• Kremers RMW, Kleinegris MC, Ninivaggi M, de Laat B, Ten Cate H, Koek GH, Wagenvoord RJ, Hemker HC. Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis. PLoS One 2017;12(5):e0177020. doi:10.1371/journal.pone.0177020. PMID:28472132.
   PubMed Web of Science ®Google Scholar
• Kremers RM, Wagenvoord RJ, Hemker HC. The effect of fibrin(ogen) on thrombin generation and decay. Thromb Haemost 2014;112(3):486–494. doi:10.1160/th14-02-0172. PMID:24964786.
   PubMed Web of Science ®Google Scholar
• Hemker HC. Thrombin generation: biochemical possibilities and clinical reality. Blood 2015;126(3):288–289. doi:10.1182/blood-2015-05-643403. PMID:26185117.
   PubMed Web of Science ®Google Scholar
• Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003;33(1):4–15. doi:10.1159/000071636. PMID: 12853707.
   PubMedGoogle Scholar
• Castoldi E, Duckers C, Radu C, Spiezia L, Rossetto V, Tagariello G, Rosing J, Simioni P. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma. J Thromb Haemost 2011;9(5):959–968. doi:10.1111/j.1538-7836.2011.04237.x. PMID:21320286.
   PubMed Web of Science ®Google Scholar
• Samama MM, Le Flem L, Guinet C, Gerotziafas G, Depasse F. Three different patterns of calibrated automated thrombogram obtained with six different anticoagulants. J Thromb Haemost 2007;5(12):2554–2556. doi:10.1111/j.1538-7836.2007.02753.x. PMID:18034769.
   PubMed Web of Science ®Google Scholar
• Cohen H, Dore CJ, Clawson S, Hunt BJ, Isenberg D, Khamashta M, Muirhead N. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. Lupus 2015;24(10):1087–1094. doi:10.1177/0961203315581207. PMID:25940537.
   PubMed Web of Science ®Google Scholar
• Douxfils J, Chatelain B, Chatelain C, Dogne JM, Mullier F. Edoxaban: impact on routine and specific coagulation assays. A practical laboratory guide. Thromb Haemost 2016;115(2):368–381. doi:10.1160/th15-05-0415. PMID:26510969.
   PubMed Web of Science ®Google Scholar
• Didelot M, Docq C, Wahl D, Lacolley P, Regnault V, Lagrange J. Platelet aggregation impacts thrombin generation assessed by calibrated automated thrombography. Platelets 2018;29(2):156–161. doi:10.1080/09537104.2017.1356452. PMID:29022492.
   PubMed Web of Science ®Google Scholar
• Hemker HC, Kremers R. Data management in thrombin generation. Thromb Res 2013;131(1):3–11. doi:10.1016/j.thromres.2012.10.011. PMID:23158401.
   PubMed Web of Science ®Google Scholar
• Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957;17(4):237–246. doi:10.1159/000205234. PMID:13434757.
   PubMedGoogle Scholar
• Kremers RM, Bosch YP, Bloemen S, de Laat B, Weerwind PW, Mochtar B, Maessen JG, Wagenvoord RJ, Al Dieri R, Hemker HC. A reduction of prothrombin conversion by cardiac surgery with cardiopulmonary bypass shifts the haemostatic balance towards bleeding. Thromb Haemost 2016;116(3):442–451. doi:10.1160/th16-02-0094. PMID:27121983.
   PubMed Web of Science ®Google Scholar
• Kremers RMW, Zuily S, Kelchtermans H, Peters TC, Bloemen S, Regnault V, Hemker HC, de Groot PG, Wahl D, de Laat B. Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin. Blood Adv 2018;2(11):1315–1324. doi:10.1182/bloodadvances.2018018036. PMID:29895622.
   PubMed Web of Science ®Google Scholar
• Kremers RM, Wagenvoord RJ, de Laat HB, Monagle P, Hemker HC, Ignjatovic V. Low paediatric thrombin generation is caused by an attenuation of prothrombin conversion. Thromb Haemost 2016;115(6):1090–1100. doi:10.1160/th15-09-0716. PMID:26819003.
   PubMed Web of Science ®Google Scholar
• NCCLS. How to define and determine reference intervals in the clinical laboratory; Approved guideline—second edition. NCCLS document C28-A2 [ISBN 1-56238-406-6]. Wayne (PA): NCCLS; 2000. 19087–11898.
   Google Scholar
• Bloemen S, Huskens D, Konings J, Kremers RM, Miszta A, de Laat B, Kelchtermans H. Interindividual variability and normal ranges of whole blood and plasma thrombin generation. J Appl Lab Med 2017;2(2):150–164. doi:10.1373/jalm.2017.023630. PMID:14988149.
   PubMedGoogle Scholar
• Mann KG, Brummel-Ziedins K, Orfeo T, Butenas S. Models of blood coagulation. Blood Cells Mol Dis 2006;36(2):108–117. doi:10.1016/j.bcmd.2005.12.034. PMID:16500122.
   PubMed Web of Science ®Google Scholar
• Hemker HC, Beguin S. Phenotyping the clotting system. Thromb Haemost 2000;84(5):747–751. doi:10.1080/003655102320754719. PMID:11127849.
   PubMed Web of Science ®Google Scholar
• Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002;22(9):1381–1389. doi:10.1161/01.atv.0000031340.68494.34. PMID:12231555.
   PubMed Web of Science ®Google Scholar
• Schols SE, Feijge MA, Lance MD, Hamulyak K, Ten Cate H, Heemskerk JW, van Pampus EC. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets. Transfusion 2008;48(11):2384–2394. doi:10.1111/j.1537-2995.2008.01872.x. PMID:18673348.
   PubMed Web of Science ®Google Scholar
• Vanschoonbeek K, Feijge M, Van Kampen RJ, Kenis H, Hemker HC, Giesen PL, Heemskerk JW. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2004;2:476–484. doi:10.1111/j.1538-7933.2004.00618.x. PMID:15009466.
   PubMed Web of Science ®Google Scholar
• Keularts IMLW, Hamulyak K, Hemker HC, Béguin S. The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients. Thromb Haemost 2000;84(4):638–642. doi:10.1055/s-0037-1614080. PMID:11057863.
   PubMed Web of Science ®Google Scholar
• Sadler JE. Von Willebrand factor. J Bio Chem 1991;266(34):22777–22780. PMID:1744071.
   PubMed Web of Science ®Google Scholar
• Rugeri L, Beguin S, Hemker C, Bordet JC, Fleury R, Chatard B, Negrier C, Dargaud Y. Thrombin-generating capacity in patients with von Willebrand’s disease. Haematologica 2007;92(12):1639–1646. doi:10.3324/haematol.11460. PMID:18055987.
   PubMed Web of Science ®Google Scholar
• Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000;28(6):1871–1876. doi:10.1097/00003246-200006000-00031. PMID:10890635.
   PubMed Web of Science ®Google Scholar
• Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002;30(8):1765–1771. doi:10.1097/00003246-200208000-00015. PMID:19767509.
   PubMed Web of Science ®Google Scholar
• Crowther MA, Cook DJ, Meade MO, Griffith LE, Guyatt GH, Arnold DM, Rabbat CG, Geerts WH, Warkentin TE. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care 2005;20(4):348–353. doi:10.1016/j.jcrc.2005.09.008. PMID:16310606.
   PubMed Web of Science ®Google Scholar
• Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood 2009;114(23):4777–4783. doi:10.1182/blood-2009-04-215525. PMID:19767509.
   PubMed Web of Science ®Google Scholar
• Arnold DM. Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program 2015;2015(1):237–242. doi:10.1182/asheducation-2015.1.237. PMID:26637728.
   PubMed Web of Science ®Google Scholar